ADC Therapeutics raises ~$105M in public offering of common shares and pre-funded warrants

ADC Therapeutics SA

Offered 13.4M common shares at $4.90/share and pre-funded warrants for 8.2M shares at $4.812/warrant.
Gross proceeds ~$105M; underwriters include Jefferies, Guggenheim, Cantor Fitzgerald; offering closed May 8, 2024.
Pre-funded warrants exercisable at CHF 0.08/share, with a 9.99% beneficial ownership cap (adjustable to 19.99%).
Warrants have a 10-year term and may be exercised on a cashless basis under certain conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.